<VariationArchive VariationID="458680" VariationName="NM_006147.4(IRF6):c.1195del (p.Ala399fs)" VariationType="Deletion" Accession="VCV000458680" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-03-30" DateCreated="2017-12-26" MostRecentSubmission="2022-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="447617" VariationID="458680">
      <GeneList>
        <Gene Symbol="IRF6" FullName="interferon regulatory factor 6" GeneID="3664" HGNC_ID="HGNC:6121" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209785617" stop="209806142" display_start="209785617" display_stop="209806142" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209958967" stop="209979519" display_start="209958967" display_stop="209979519" Strand="-" />
          </Location>
          <OMIM>607199</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IRF6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IRF6">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006147.4(IRF6):c.1195del (p.Ala399fs)</Name>
      <CanonicalSPDI>NC_000001.11:209788628:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209788629" stop="209788629" display_start="209788629" display_stop="209788629" variantLength="1" positionVCF="209788628" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209961974" stop="209961974" display_start="209961974" display_stop="209961974" variantLength="1" positionVCF="209961973" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A399fs</ProteinChange>
      <ProteinChange>A304fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.209961975del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.209961975del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.209788630del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.209788630del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007081.2" sequenceAccession="NG_007081" sequenceVersion="2" change="g.22506del">
            <Expression>NG_007081.2:g.22506del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001206696.2" sequenceAccession="NM_001206696" sequenceVersion="2" change="c.910del">
            <Expression>NM_001206696.2:c.910del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001193625.1" sequenceAccession="NP_001193625" sequenceVersion="1" change="p.Ala304fs">
            <Expression>NP_001193625.1:p.Ala304fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006147.4" sequenceAccession="NM_006147" sequenceVersion="4" change="c.1195del" MANESelect="true">
            <Expression>NM_006147.4:c.1195del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006138.1" sequenceAccession="NP_006138" sequenceVersion="1" change="p.Ala399fs">
            <Expression>NP_006138.1:p.Ala399fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658655632" DB="ClinGen" />
        <XRef Type="rs" ID="1553247602" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006147.4(IRF6):c.1195del (p.Ala399fs) AND Van der Woude syndrome 1" Accession="RCV000531368" Version="1">
        <ClassifiedConditionList TraitSetID="874">
          <ClassifiedCondition DB="MedGen" ID="C4551864">Van der Woude syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006147.4(IRF6):c.1195del (p.Ala399fs) AND multiple conditions" Accession="RCV001386450" Version="4">
        <ClassifiedConditionList TraitSetID="65852">
          <ClassifiedCondition DB="MedGen" ID="C1837213">Orofacial cleft 6, susceptibility to</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265259">Popliteal pterygium syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0175697">Van der Woude syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-31" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2017-12-26" MostRecentSubmission="2022-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="874" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5097" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Van der Woude syndrome 1</ElementValue>
                <XRef ID="MONDO:0007333" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cleft lip and/or palate with mucous cysts of lower lip</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VWS1</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Most commonly, IRF6-related disorders span a spectrum from isolated cleft lip and palate and Van der Woude syndrome (VWS) at the mild end to popliteal pterygium syndrome (PPS) at the more severe end. In rare instances, IRF6 pathogenic variants have also been reported in individuals with nonsyndromic orofacial cleft (18/3,811; 0.47%) and in individuals with spina bifida (2/192). Individuals with VWS show one or more of the following anomalies: Congenital, usually bilateral, paramedian lower-lip fistulae (pits) or sometimes small mounds with a sinus tract leading from a mucous gland of the lip. Cleft lip (CL). Cleft palate (CP). Note: Cleft lip with or without cleft palate (CL±P) is observed about twice as often as CP only. Submucous cleft palate (SMCP). The PPS phenotype includes the following: CL±P. Fistulae of the lower lip. Webbing of the skin extending from the ischial tuberosities to the heels. In males: bifid scrotum and cryptorchidism. In females: hypoplasia of the labia majora. Syndactyly of fingers and/or toes. Anomalies of the skin around the nails. A characteristic pyramidal fold of skin overlying the nail of the hallux (almost pathognomonic). In some nonclassic forms of PPS: filiform synechiae connecting the upper and lower jaws (syngnathia) or the upper and lower eyelids (ankyloblepharon). Other musculoskeletal anomalies may include spina bifida occulta, talipes equinovarus, digital reduction, bifid ribs, and short sternum. In VWS, PPS, IRF6-related neural tube defect, and IRF6-related orofacial cleft, growth and intelligence are typical.</Attribute>
                <XRef ID="NBK1407" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301581</ID>
                <ID Source="BookShelf">NBK1407</ID>
              </Citation>
              <XRef ID="C4551864" DB="MedGen" />
              <XRef ID="MONDO:0007333" DB="MONDO" />
              <XRef Type="MIM" ID="119300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="65852" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3124" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 6</ElementValue>
                <XRef Type="MIM" ID="608864" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Orofacial cleft 6, susceptibility to</ElementValue>
                <XRef ID="Orofacial+cleft+6%2C+susceptibility+to/9044" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012141" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OFC6</ElementValue>
                <XRef Type="MIM" ID="608864" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18304" />
                <XRef ID="18304" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1837213" DB="MedGen" />
              <XRef ID="MONDO:0012141" DB="MONDO" />
              <XRef Type="MIM" ID="608864" DB="OMIM" />
            </Trait>
            <Trait ID="4007" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Popliteal pterygium syndrome</ElementValue>
                <XRef ID="Popliteal+pterygium+syndrome/5870" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017435" DB="MONDO" />
                <XRef ID="66783006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPS</ElementValue>
                <XRef Type="MIM" ID="119500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="21189" />
                <XRef ID="21189" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most commonly, IRF6-related disorders span a spectrum from isolated cleft lip and palate and Van der Woude syndrome (VWS) at the mild end to popliteal pterygium syndrome (PPS) at the more severe end. In rare instances, IRF6 pathogenic variants have also been reported in individuals with nonsyndromic orofacial cleft (18/3,811; 0.47%) and in individuals with spina bifida (2/192). Individuals with VWS show one or more of the following anomalies: Congenital, usually bilateral, paramedian lower-lip fistulae (pits) or sometimes small mounds with a sinus tract leading from a mucous gland of the lip. Cleft lip (CL). Cleft palate (CP). Note: Cleft lip with or without cleft palate (CL±P) is observed about twice as often as CP only. Submucous cleft palate (SMCP). The PPS phenotype includes the following: CL±P. Fistulae of the lower lip. Webbing of the skin extending from the ischial tuberosities to the heels. In males: bifid scrotum and cryptorchidism. In females: hypoplasia of the labia majora. Syndactyly of fingers and/or toes. Anomalies of the skin around the nails. A characteristic pyramidal fold of skin overlying the nail of the hallux (almost pathognomonic). In some nonclassic forms of PPS: filiform synechiae connecting the upper and lower jaws (syngnathia) or the upper and lower eyelids (ankyloblepharon). Other musculoskeletal anomalies may include spina bifida occulta, talipes equinovarus, digital reduction, bifid ribs, and short sternum. In VWS, PPS, IRF6-related neural tube defect, and IRF6-related orofacial cleft, growth and intelligence are typical.</Attribute>
                <XRef ID="NBK1407" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301581</ID>
                <ID Source="BookShelf">NBK1407</ID>
              </Citation>
              <XRef ID="294963" DB="Orphanet" />
              <XRef ID="C0265259" DB="MedGen" />
              <XRef ID="MONDO:0017435" DB="MONDO" />
            </Trait>
            <Trait ID="55926" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Van der Woude syndrome</ElementValue>
                <XRef ID="Van+der+Woude+syndrome/7346" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019508" DB="MONDO" />
                <XRef ID="79261008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lip pit syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VDWS</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PIT</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VWS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LPS</ElementValue>
                <XRef Type="MIM" ID="119300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8414" />
                <XRef ID="8414" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="888" DB="Orphanet" />
              <XRef ID="C0175697" DB="MedGen" />
              <XRef ID="MONDO:0019508" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1222299" SubmissionDate="2017-10-05" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1977189|MedGen:C0175697" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000630081" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">This sequence change deletes 1 nucleotide from exon 9 of the IRF6 mRNA (c.1195delG), causing a frameshift at codon 399. This creates a premature translational stop signal in the last exon of the IRF6 mRNA (p.Ala399Leufs*3). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 69 amino acids of the IRF6 protein. This variant has not been reported in the literature in individuals with a IRF6-related disease. A different truncation downstream of this variant (p.Arg412*) has been determined to be pathogenic, as it is one of the most common variants reported in individuals affected with Van der Woude syndrome (PMID: 12219090, 19282774, 23154523, 25784454). This suggests that deletion of this region of the IRF6 protein is causative of disease. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IRF6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006147.3:c.1195delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0175697" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3112328" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="1977189|MedGen:C1837213;C0175697;C0265259" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586678" DateUpdated="2022-05-16" DateCreated="2021-05-10" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IRF6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.209961974del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837213" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0175697" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265259" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3112328" TraitType="Disease" MappingType="XRef" MappingValue="C0175697" MappingRef="MedGen">
        <MedGen CUI="C0175697" Name="Van der Woude syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112328" TraitType="Disease" MappingType="XRef" MappingValue="C1837213" MappingRef="MedGen">
        <MedGen CUI="C1837213" Name="Orofacial cleft 6, susceptibility to" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1222299" TraitType="Disease" MappingType="XRef" MappingValue="C0175697" MappingRef="MedGen">
        <MedGen CUI="C0175697" Name="Van der Woude syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112328" TraitType="Disease" MappingType="XRef" MappingValue="C0265259" MappingRef="MedGen">
        <MedGen CUI="C0265259" Name="Popliteal pterygium syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

